Nootkatone Ameliorates Doxorubicin Induced Myocardial Injury through Modulation of NF-κB Signals and Oxidative Stress
Cellular Physiology and Biochemistry · 25.08.2022 · 56 (4) · 401-417
DOI: 10.33594/000000559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, online erschienen am 25.08.2022. Verfasst von Suhail Al-Salam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates, suhaila@uaeu.ac.ae. Hauptthemen laut MEDLINE: Heart Injuries, NF-kappa B. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Gefördert von: College of Medicine & Health Sciences, UAE University, The Zayed Bin Sultan Center for Health Sciences, UAE University.
Abstract (Originalsprache)
BACKGROUND/AIMS: Doxorubicin (DOXO) is a potent chemotherapeutic drug that is used in the treatment of a large number of cancers. Despite its important chemotherapeutic characteristics, its usage is limited because of the serious side effects; the most noticeable is cardiotoxicity which can manifest acutely or years after completion of treatment leading to left ventricular dysfunction, dilated cardiomyopathy and heart failure. Nootkatone (NK) is a recognized bioactive compound isolated from the heartwood of Cupressus nootkatensis and has been reported to have antiseptic, antioxidant, and anti-allergic activities. METHODS: Male C57B6/J mice were used for mice model of DOXO-cardiac toxicity. Mice were given either DOXO or NK or DOXO+NK or vehicle (normal saline) after which the mice again had free access to food and water. Heart and plasma samples were collected 5 days after DOXO administration and were used for immunohistochemistry, electron microscopy and enzyme linked immunosorbent assay (ELISA). RESULTS: There were significant reduction in inflammatory markers in hearts of DOXO-NK- treated mice when compared with DOXO-treated mice. Moreover, there were significant increase in antioxidant proteins and reduction of oxidative stress in hearts of DOXO-NK-treated mice when compared with DOXO-treated mice. There was a significant reduction in myocardial damage as shown by significant reduction of troponin I in DOXO-NK- treated mice when compared with DOXO-treated mice. CONCLUSION: Nootkatone improves DOXO-induced myocardial injury through modulation of NF-κB signals and reduction of oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates, suhaila@uaeu.ac.ae.
- Department of Pathology, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
- Department of Anatomy, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Förderung
- College of Medicine & Health Sciences, UAE University
- The Zayed Bin Sultan Center for Health Sciences, UAE University
Zitieren
APA
Al-Salam, S., Kandhan, K., Sudhadevi, M., & Tariq, S. (2022). Nootkatone Ameliorates Doxorubicin Induced Myocardial Injury through Modulation of NF-κB Signals and Oxidative Stress. Cellular Physiology and Biochemistry, 56(4), 401-417. https://doi.org/10.33594/000000559
Vancouver
Al-Salam S, Kandhan K, Sudhadevi M, Tariq S. Nootkatone Ameliorates Doxorubicin Induced Myocardial Injury through Modulation of NF-κB Signals and Oxidative Stress. Cellular Physiology and Biochemistry. 2022;56(4):401-417. doi:10.33594/000000559
BibTeX
@article{AlSalam2022,
author = {Al-Salam, Suhail and Kandhan, Karthishwaran and Sudhadevi, Manjusha and Tariq, Saeed},
title = {Nootkatone Ameliorates Doxorubicin Induced Myocardial Injury through Modulation of NF-κB Signals and Oxidative Stress},
journal = {Cellular Physiology and Biochemistry},
year = {2022},
volume = {56},
number = {4},
pages = {401--417},
doi = {10.33594/000000559}
}
EUVIMED